Last updated on November 2018

A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors

Brief description of study

The purpose of this open-label nonrandomized Phase 1/2 study is to evaluate INCB001158 in combination with chemotherapy in participants with advanced/metastatic solid tumors.

Clinical Study Identifier: NCT03314935

Contact Investigators or Research Sites near you

Start Over

Incyte Corporation Call Center (US)

Institut Jules Bordet - Clinical Trials Conduct Unit
Brussels, Belgium
  Connect »

Incyte Corporation Call Center (US)

Grand Hopital de Charleroi - Department of Medical Oncology
Brussels, Belgium
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.